Novo Nordisk A/S - share repurchase programme
May 06 2024 - 2:44PM
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 06 May 2024 – The execution
of Novo Nordisk A/S’ overall share repurchase programme for 2024 of
DKK 20 billion continues. As part of this, Novo Nordisk A/S has now
initiated a new share repurchase programme of up to DKK 2.2 billion
in accordance with Article 5 of Regulation No 596/2014 of the
European Parliament and Council of 16 April 2014 (MAR) and the
Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the
"Safe Harbour Rules”).
The purpose of the programme is to reduce the company’s share
capital and to meet obligations arising from share-based incentive
programmes. B shares of DKK 0.10 will be repurchased during the
trading period starting 7 May 2024 and ending on 5 August 2024. A
maximum of 350,000,000 B shares of DKK 0.10 in total can be bought
during the trading period.
Novo Nordisk is a leading global healthcare company, founded in
1923 and headquartered in Denmark. Our purpose is to drive change
to defeat serious chronic diseases, built upon our heritage in
diabetes. We do so by pioneering scientific breakthroughs,
expanding access to our medicines, and working to prevent and
ultimately cure disease. Novo Nordisk employs about 66,000 people
in 80 countries and markets its products in around 170 countries.
Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B).
Its ADRs are listed on the New York Stock Exchange (NVO). For more
information, visit novonordisk.com, Facebook, Instagram, X,
LinkedIn and YouTube.
Contact for further information
Media: |
|
Ambre
James-Brown +45 3079 9289abmo@novonordisk.com |
Liz
Skrbkova (US)+1 609 917 0632lzsk@novonordisk.com |
Investors: |
|
Daniel
Muusmann Bohsen+45 3075 2175 dabo@novonordisk.com |
Jacob
Martin Wiborg Rode+45 3075 5956jrde@novonordisk.com |
David
Heiberg Landsted +45 3077 6915 dhel@novonordisk.com |
Mark
Joseph Root (US) +1 848 213 3219mjhr@novonordisk.com |
Sina
Meyer +45 3079 6656azey@novonordisk.com |
Frederik
Taylor Pitter +45 3075 8259fptr@novonordisk.com |
Ida
Melvold Gjøsund+45 3077 5649 idmg@novonordisk.com |
|
Company announcement No 38 / 2024
Novo Nordisk (TG:NOV)
Historical Stock Chart
From Apr 2024 to May 2024
Novo Nordisk (TG:NOV)
Historical Stock Chart
From May 2023 to May 2024